Role of Children in Transmission of COVID-19 to Immunocompromised Patients
NCT04407546 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 109
Last updated 2023-03-24
Summary
This is a study of immunosuppressed individuals living in households with and without children to assess the role of household contact with children in the transmission of SARSCoV-2 to immunocompromised individuals. Through careful collection of epidemiological data in combination with biological specimens, risk factors for SARS-CoV-2 in immunocompromised individuals will be identified. During the initial visits, informed consent will be obtained and consented participants will complete an initial questionnaire and provide biological specimens including nasal swabs, saliva and blood. Thereafter, participants will complete at-home saliva collections and questionnaires on a weekly basis for 6 months. If our research-use only SARS-CoV-2 test is positive, participants will be referred immediately for medical attention and will be followed every 3 days with nasal swabs and saliva samples and weekly blood specimens and optional rectal swabs or fresh stool collection. Additionally, participants will be contacted by telephone at 1 year for follow-up.
Conditions
- Immunosuppression
Sponsors & Collaborators
-
Jonsson Comprehensive Cancer Center
lead OTHER
Principal Investigators
-
Grace Aldrovandi, M.D. · University of Califiornia at Los Angeles
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-05-27
- Primary Completion
- 2023-03-13
- Completion
- 2023-03-13
Countries
- United States
Study Locations
More Related Trials
-
The Predictability of CD19 Expression Across Primitive Cellular Fractions of Relapsed B-ALL on Outcomes of CD19-targeted CAR T-cells
NCT06993766 ·Status: NOT_YET_RECRUITING
-
A Pilot Study of Tumor-Specific Peptide Vaccination and IL-2 With or Without Autologous T Cell Transplantation in Recurrent Pediatric Sarcomas
NCT00001564 ·Status: COMPLETED ·Phase: PHASE2
-
Phase I Study of Ipilimumab (Anti-CTLA-4) in Children and Adolescents With Treatment-Resistant Cancer
NCT01445379 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, Efficacy and Pharmacokinetics of Copanlisib in Pediatric Patients
NCT03458728 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
A Prediction Model of Hematological Recovery After High-dose Chemotherapy in Pediatric Solid Tumor
NCT05024331 ·Status: COMPLETED
-
Allogeneic Tumor Cell Vaccination in Patients With Solid Tumors
NCT00148993 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Preliminary Efficacy of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) in Pediatric and Young Adult Participants With Solid Tumors
NCT02541604 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
A Multi-Institution Study of TGFβ Imprinted, Ex Vivo Expanded Universal Donor NK Cell Infusions as Adoptive Immunotherapy in Combination With Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Pediatric Bone and Soft Tissue
NCT05634369 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Pharmacogenetically Based Dosing of Thiopurines in Childhood Acute Lymphoblastic Leukemia
NCT01678508 ·Status: COMPLETED
-
Treatment of Newly Diagnosed High Risk Pediatric Acute Lymphoblastic Leukemia
NCT06184009 ·Status: RECRUITING ·Phase: PHASE2
-
Therapy to Treat Ewing's Sarcoma, Rhabdomyosarcoma or Neuroblastoma
NCT00923351 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Dissecting Tumour MicroenvirOnment in Solid Paediatric Tumour to Improve Adoptive Cell Therapy
NCT07240207 ·Status: RECRUITING
-
EXOme Rare Cancers in Children (EXOCARE)
NCT03472807 ·Status: TERMINATED ·Phase: NA
-
Vaccine Therapy in Preventing Flu in Children With Acute Lymphoblastic Leukemia
NCT00022035 ·Status: COMPLETED ·Phase: NA
-
Cardiometabolic Status in Childhood Acute Lymphoblastic Leukemia
NCT01688752 ·Status: WITHDRAWN
-
A Study of Lenvatinib (MK-7902) in Pediatric Participants With Relapsed or Refractory Solid Malignancies (MK-7902-013/E7080)
NCT04447755 ·Status: COMPLETED ·Phase: PHASE2
-
BL22 Immunotoxin In Treating Young Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma
NCT00077493 ·Status: SUSPENDED ·Phase: PHASE1
-
A Study of Safety, Tolerability, and Pk of rhMBL in Pediatric Hematology/Oncology Pts With Fever and Neutropenia
NCT00520325 ·Status: WITHDRAWN ·Phase: PHASE1
-
Study of Talimogene Laherparepvec In Children With Advanced Non CNS Tumors
NCT02756845 ·Status: COMPLETED ·Phase: PHASE1
-
Post Mortem Tissue Donation of Pediatric Tumor Tissues and Cells
NCT05120518 ·Status: RECRUITING
-
CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Synovial Sarcoma
NCT04145700 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Nebulized Amphotericin B Lipid Complex in Invasive Pulmonary Aspergillosis in Paediatric Patients With Acute Leukaemia
NCT01615809 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Adoptive Immunotherapy in Relapsed and Non-resectable Sarcomas After Multimodal Treatment.
NCT03782363 ·Status: WITHDRAWN ·Phase: PHASE1
-
A Study to Evaluate Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of Tripegfilgrastim in Pediatric Solid Tumor/Lymphoma Patients
NCT02963389 ·Status: COMPLETED ·Phase: PHASE1
-
Multi-centre Prospective Cohort of Childhood Leukaemia: Determinants of Health and Quality of Life of the Patients After Treatment for an Acute Leukaemia During Childhood or Adolescence - LEA
NCT01756599 ·Status: UNKNOWN ·Phase: NA